Short description
Brainomix specializes in the creation of AI-powered imaging biomarkers that enable precision medicine for better treatment decisions
Description
Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions.
Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providing real-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
Last funding
Absolutely Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Oxford, Oxfordshire, United Kingdom, Europe
Founded on
January 1, 2010
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noaccess, Absolutely Noaccess, Absolutely Noaccess, Noway Youcantaccess, Cannot Access, Noaccess, Noaccess
Sign in for full access
Founders
Andrew Barker, Michalis Papadakis